Medical Reading


Change Your Brain, Change Your Life (Revised and Expanded) by Daniel G. Amen MD Published by Harmony Renowned neuropsychiatrist Dr Daniel Amen uses cutting-edge research and the latest effective “brain prescriptions” to help heal your brain and change your life. Completely revised and updated, this edition of the breakthrough best-seller Change Your Brain, Change Your […]

UK: Mylan Launches Generic Avodart Capsules

Mylan NV announced the US launch of Dutasteride Capsules, 0.5 mg, the generic version of GlaxoSmithKlineʼs Avodart Capsules. Mylan received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated as monotherapy for the treatment of symptomatic benign prostatic hyperplasia (BPH) in […]

USA: Pfizer Completes Acquisition of Anacor

Pfizer Inc. has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net in cash (without interest but subject to required withholding of taxes). “Now that Anacor is part of Pfizer, we can accelerate our […]

SWITZERLAND & IRELAND: World Stroke Organization and Medtronic Collaborate to Increase Stroke Awareness


The World Stroke Organization (WSO) has partnered with Medtronic PLC to increase stroke awareness through several initiatives. The two organisations will work together to educate, raise awareness, and support effective management of patients who have strokes. The partnership, announced at the 2016 Annual Scientific Session of the Chinese Stroke Association (CSA) and Tiantan International Stroke […]

USA: Premier Inc Recognises Health System and Supplier Recipients of 2016

Premier Inc recognised approximately 150 health systems and suppliers this week with a 2016 Breakthroughs Award for transforming healthcare. “Recipients of Premier’s 2016 Breakthroughs Awards are industry leaders that are truly making a difference in healthcare,” said Susan DeVore, president and CEO, Premier. “We congratulate and thank them for their tireless efforts to improve care […]

FRANCE: Calixar and University of Avignon to Launch New Research Lab Developing Innovative Chemistry For Target Discovery

Calixar, the French biotech company specialised in the native isolation of membrane therapeutic targets/antigens and the French University of Avignon — Bio-organic Chemistry and Amphiphilic Systems Team (CBSA) — announced the official launch of the CHEM2STAB Laboratory (CHEMistry for STABilization) supported by the French National Research Agency (ANR). CHEM2STAB is a unique laboratory in the […]

USA: Life Spine’s Centric Medical Wins FDA Clearance for Flatfoot Implant


Centric Medical, a division of Life Spine, Inc, which focuses on developing surgical implants for the treatment of distal extremity pathology, announced recently that the US Food and Drug Administration (FDA) has given 510(k) marketing clearance to the Subtalar Arthroereisis Implant System for treating hyperpronation of the foot and stabilisation of the subtalar joint. The […]

CHINA: Spring Rain Mobile Healthcare App Raises $183 Million

Spring Rain Software, a Beijing mobile healthcare app company, raised $183 million from China International Capital Corporation in a pre-IPO round. A major player in the crowded online healthcare sector, Spring Rain is known as Chunyu Yishing in Chinese. According to Tencent Technology, the company has not fully committed to an IPO. It may spin […]

IRELAND: New Research Demonstrates Support for ‘Bring Your Own Device’ Approach in Clinical Trials


ICON PLC, a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries, recently announced research showing many pharmaceutical and clinical research organisations (CROs) support the use of a ‘Bring Your Own Device’ (BYOD) approach in clinical studies, enabling patients to use their own mobile devices to collect patient-reported […]

USA: City Of Hope, Novonco Announce First-In-Human Clinical Trial For COH29

City of Hope and Novonco Therapeutics Inc recently announced the initiation of a phase 1, first-in-human clinical trial for a promising anti-cancer drug — COH29 — that will be used to treat patients with solid tumours, including breast, colon, ovarian, pancreatic, stomach, and lung cancers. Patients whose disease is treatment-resistant to standard therapies, or for […]

Copyright © 2013 All rights reserved. Content and images are meant for practicing medical doctors, allied health care professionals and other establishments in the medical industry. Reproduction or redistribution of any content and images, is prohibited without the prior written consent of Ezyhealth Media Pte Ltd.